Literature DB >> 27448089

pH-Triggered Sustained Drug Delivery from a Polymer Micelle having the β-Thiopropionate Linkage.

Prithankar Pramanik1, Debdatta Halder2, Siddhartha Sankar Jana3, Suhrit Ghosh4.   

Abstract

The synthesis, micellar aggregation, and pH-triggered intracellular drug delivery ability of an amphiphilic statistical copolymer (P2) are studied. Two methacrylate derivatives, one containing a hydrophilic pendant and the other containing a hydrophobic pendant chain, are copolymerized to produce P2. The hydrophobic pendant chain is linked to the polymer backbone by a β-thiopropionate linkage, known to undergo slow hydrolysis at mild acidic pH. P2 forms a multimicellar cluster in water with a critical aggregation concentration of 0.02 mg mL(-1) and encapsulates a hydrophobic guest such as pyrene, Nile red, or the anti-cancer drug doxorubicin (Dox). Sustained release of the entrapped Dox (80% after 100 h) is noticed at pH 5.2, while release is significantly slower (35% after 100 h) at pH 7.4. Acidic hydrolysis of the β-thiopropionate linkage leading to the reduction of the hydrophobicity is established as the cause for micellar disassembly and triggered drug release. Cell-culture studies with the human breast cancer cell line, MCF-7, reveal biocompatibility of P2 (below 150 μg mL(-1) ). It is further tested for intracellular delivery of Dox. MCF-7 cells remain healthy at pH 7.4 but become unhealthy at pH 5.2 when treated with a Dox-loaded P2 micelles.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  amphiphilic polymers; doxorubicin; drug delivery; pH-responsive micelles; β-thiopropionate linkages

Mesh:

Substances:

Year:  2016        PMID: 27448089     DOI: 10.1002/marc.201600260

Source DB:  PubMed          Journal:  Macromol Rapid Commun        ISSN: 1022-1336            Impact factor:   5.734


  4 in total

1.  Engineering Camptothecin-Derived Norbornene Polymers for Theranostic Application.

Authors:  Saikat Mukherjee; Himadri Dinda; Ipsita Chakraborty; Rangeet Bhattacharyya; Jayasri Das Sarma; Raja Shunmugam
Journal:  ACS Omega       Date:  2017-06-21

2.  Targeted delivery by pH-responsive mPEG-S-PBLG micelles significantly enhances the anti-tumor efficacy of doxorubicin with reduced cardiotoxicity.

Authors:  Qiyi Feng; Junhuai Xu; Xinyi Liu; Haibo Wang; Junjie Xiong; Kai Xiao
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.819

3.  Programmed supramolecular nanoassemblies: enhanced serum stability and cell specific triggered release of anti-cancer drugs.

Authors:  Sanchaita Mondal; Moumita Saha; Mousumi Ghosh; Subrata Santra; Mijan A Khan; Krishna Das Saha; Mijanur R Molla
Journal:  Nanoscale Adv       Date:  2019-02-01

Review 4.  Nanomedicine applications in the treatment of breast cancer: current state of the art.

Authors:  Di Wu; Mengjie Si; Hui-Yi Xue; Ho-Lun Wong
Journal:  Int J Nanomedicine       Date:  2017-08-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.